|
|
|
Partnering with the Leader In Therapeutic Antibodies provides an immediate competitive advantage in the ability to discover therapeutic antibodies that meet or exceed design goals based on aggressive medical and commercial objectives. Our antibody discovery platform is comprehensive, and includes the world’s largest collection of leading commercial Antibody Phage Display libraries and XOMA’s proprietary Human Engineering™ technology, as well as other technologies for antibody optimization. Partners can also benefit from XOMA’s product development culture and fully integrated biologics development infrastructure to pull antibody products through preclinical sciences to product launch in a seamless, simplified approach. This unique combination of technologies, expertise, and infrastructure positions XOMA to rapidly generate antibody products and deliver them to the market in a time-efficient manner. Partner with XOMA to accelerate product development, increase the probability of technical and business success, and realize financial advantages. We offer flexible deal structures and tailor each relationship to meet the needs of our partner and the product program. |
©XOMA 2008